Back
Lyra Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
23
LYRA
Lyra Therapeutics
Last Price:
$9.30
Seasonality Move:
-2.29%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lyra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.62 | Sell |
20-day SMA: | 11.35 | Sell |
50-day SMA: | 9.49 | Sell |
200-day SMA: | 9.73 | Sell |
8-day EMA: | 2.06 | Buy |
20-day EMA: | 0.88 | Buy |
50-day EMA: | 0.36 | Buy |
200-day EMA: | 0.09 | Buy |
Lyra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.74 | Buy |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | 36962 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.26 - 19.52) | Sell |
Bollinger Bands (100): | (4.04 - 13.16) | Buy |
Lyra Therapeutics Technical Analysis
Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lyra Therapeutics Stock
Is Lyra Therapeutics Stock a Buy?
-
Lyra Therapeutics share price is 9.25 while LYRA 8-day simple moving average is 9.62, which is a Sell signal.
-
The stock price of LYRA is 9.25 while Lyra Therapeutics 20-day SMA is 11.35, which makes it a Sell.
-
Lyra Therapeutics 50-day simple moving average is 9.49 while LYRA share price is 9.25, making it a Sell technically.
-
LYRA stock price is 9.25 and Lyra Therapeutics 200-day simple moving average is 9.73, creating a Sell signal.
LYRA Technical Analysis vs Fundamental Analysis
Sell
23
Lyra Therapeutics (LYRA)
is a Sell
Is Lyra Therapeutics a Buy or a Sell?
-
Lyra Therapeutics stock is rated a SellThe current Lyra Therapeutics [LYRA] share price is $9.25. The Score for LYRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Lyra Therapeutics Stock Info
Market Cap:
12.3M
Price in USD:
9.25
Share Volume:
72.5K
Lyra Therapeutics 52-Week Range
52-Week High:
37.50
52-Week Low:
3.81
Sell
23
Lyra Therapeutics (LYRA)
is a Sell
Lyra Therapeutics Share Price Forecast
-
What is the Lyra Therapeutics stock price today?The Lyra Therapeutics stock price is 9.25 USD today.
-
Will LYRA stock go up or go down?Lyra Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lyra Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyra Therapeutics is overvalued.
Is Lyra Therapeutics Stock a Buy?
-
Lyra Therapeutics share price is 9.25 while LYRA 8-day exponential moving average is 2.06, which is a Buy signal.
-
The stock price of LYRA is 9.25 while Lyra Therapeutics 20-day EMA is 0.88, which makes it a Buy.
-
Lyra Therapeutics 50-day exponential moving average is 0.36 while LYRA share price is 9.25, making it a Buy technically.
-
LYRA stock price is 9.25 and Lyra Therapeutics 200-day simple moving average is 0.09, creating a Buy signal.
Fundamental Analysis of Lyra Therapeutics
Is Lyra Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Technical Analysis of Lyra Therapeutics
Should I short Lyra Therapeutics stock?
-
LYRA Moving Average Covergence Divergence (MACD) indicator is 0.74, suggesting Lyra Therapeutics is a Buy
-
Lyra Therapeutics Relative Strength Index (RSI) is 45.11, which suggest Lyra Therapeutics is oversold
-
The Bollinger Bands (25) for Lyra Therapeutics is (8.26 - 19.52), which suggest Lyra Therapeutics is a Buy
-
The Bollinger Bands (100) for Lyra Therapeutics is (4.04 - 13.16), which suggest Lyra Therapeutics is a Buy
* Lyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.